DailyIQ
|
Sector:Real EstateAll sectors
Last updated 2 minutes ago

VTR·Ventas, Inc.

$.
+. (+.%)
After Hours
High
$95.06
Open
$92.43
Market Cap
46.74B
52W High
$94.84
Low
$92.29
P. Close
$95.03
P/E
179.48
52W Low
$64.75
Fwd P/E
864.00
DailyIQ Est.
$99.95
Technical Score (1D)
95
BUY
News Sentiment
77
BULLISH
Ventas’ latest commentary has highlighted its high dividend yield potential, positioning the REIT as a compelling income play for traders eyeing stable payouts. This focus on dividends comes as the company’s payout history has remained steady, reinforcing its appeal to income‑focused investors over the next ten trading days. At the same time, Jefferies has lifted its price target to $109 from $100, citing expectations of stronger earnings growth and an improved margin profile. The upgrade signals confidence that Ventas can deliver value, which may lift sentiment and attract new buyers ahead of the upcoming earnings release. Together, the dividend narrative and the bullish price target suggest a dual‑faced upside: income stability coupled with potential upside from earnings beats. Traders should monitor the next earnings announcement for guidance that could confirm the margin improvement and validate the higher target. Additionally, keep an eye on the REIT’s occupancy rates and debt levels, as these metrics directly influence both dividend sustainability and earnings prospects. Finally, watch for any regulatory updates affecting the real‑estate sector, as changes could impact Ventas’ operating environment and, by extension, its dividend policy.
Earnings Summary
Ventas, Inc. (VTR) is a real‑estate investment trust that focuses on properties serving an aging population, with a portfolio of roughly 1,400 senior housing communities, outpatient medical facilities, research centers, and other healthcare‑related assets across North America and the United Kingdom. The company operates within the REIT‑Healthcare Facilities sector, leveraging operational expertise and data‑driven insights to deliver value in the longevity economy. In the most recent quarters, Ventas posted a strong earnings trajectory, with Q4 2025 EPS of $0.89 versus an estimate of $0.0848 and revenue of $1.566 billion against a forecast of $1.522 billion, followed by Q1 2026 EPS of $0.94 versus $0.10 and revenue of $1.657 billion versus $1.576 billion; both quarters represented higher growth than the prior two quarters (Q3 2025 EPS $0.121, revenue $1.489 billion; Q2 2025 EPS $0.15, revenue $1.421 billion), indicating an acceleration in both earnings and top line. Ventas has consistently beat analyst estimates in every quarter reported, with EPS exceeding guidance in all six periods and revenue growth maintained year‑over‑year. Historically, the company has shown a steady upward trajectory in both revenue and earnings, with no missed estimates and a pattern of expanding margins driven by occupancy and operating efficiencies. Recent analyst activity underscores this trend: Scotiabank lifted its price target to $93, Barclays initiated coverage with an equal‑weight rating and $99 target, and Evercore ISI raised its target to $96, all reflecting confidence in continued revenue growth and margin expansion; the appointment of Andrew L. Wattula as EVP of Outpatient Medical & Research signals a strategic push into outpatient services that could diversify income. Investors should watch the upcoming Q2 2026 earnings release for guidance on revenue drivers, cost‑control measures, capital expenditures, and debt metrics, as well as any commentary on the outpatient portfolio and potential acquisitions, to gauge whether the company can sustain its earnings beat and meet the heightened expectations set by recent analyst upgrades.

EPS

EstBeatMiss
$-0.08$0.21$0.49$0.78$1.07Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$0.11 - -
Q1'26$0.10$0.94+840.0%
Q4'25$0.08$0.89+949.5%
Q3'25$0.05$0.12+141.9%
Q2'25$0.14$0.15+10.4%
Q1'25$0.07$0.10+35.8%

Revenue

EstBeatMiss
$1.3B$1.4B$1.5B$1.6B$1.7BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.7B - -
Q1'26$1.6B$1.7B+5.1%
Q4'25$1.5B$1.6B+2.9%
Q3'25 - $1.5B -
Q2'25 - $1.4B -
Q1'25 - $1.4B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

VTR Stock Snapshot

VTR is currently trading at $95.04, giving Ventas, Inc. a market cap of 46.74B and a P/E ratio of 179.5. Today's range spans $92.29–$95.06, with shares opening at $92.43 and moving up $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 77/100.

Over the past year VTR has traded between $64.75 and $94.84 - the current price is +46.8% off the 52-week low and +0.2% from the high. 28 analysts cover the stock with a Buy consensus and a mean 12-month target of $97.41 (range $86.00–$110.00), implying upside of +2.5%.

VTR scores 95/100 (BUY) and is at $95.04 - near 52-week highs within its $64.75–$94.84 annual range. Sentiment at 77/100 is bullish. At 46.74B in Real Estate market cap (P/E: 179.5), this large-cap name benefits from a dynamic that mega-caps don't have: the potential for multiple expansion. When a name at this size with bullish momentum catches the attention of large allocators, the re-rating can be rapid and meaningful.

What makes VTR's BUY setup (95/100) particularly actionable at 46.74B in Real Estate capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $95.04 (near 52-week highs in $64.75–$94.84), with sentiment running bullish at 77/100, the setup rewards conviction-sized positioning more than it does speculative small bets.